Amgen, Magellan Rx Partner To Improve Consumer Care For Chronic, Difficult-To-Treat Conditions

Magellan Rx—Magellan Health’s (Magellan) fully-integrated pharmacy benefit manager (PBM) offering —and Amgen are forming a multi-year partnership to improve consumer care for chronic and difficult-to-treat conditions. Amgen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.

The collaboration will focus on the conditions of osteoporosis and migraines, considered two of the more difficult-to-treat conditions in health care. According to statements from Magellan leadership, the two organizations have a unique testing opportunity that can offer real-world evidence, which can in turn be used to create value and insights for health . . .